EVALUATION-MANAGEMENT OF BLADDER CANCER PATIENTS

合作的临床研究工作的目标是改进 不同护理方法对膀胱癌患者的护理 临床管理的各个方面。研究是根据以下规定进行的 精心设计的协议。中央病理实验室负责 统一收集、归类和分析病理组织学资料 细胞学材料。一个统计协调中心负责 数据收集、组织和分析，管理中心是 负责项目的协调和控制。在每次参与时 机构，具体目标是：1.评估和表征所有 膀胱癌患者、他们的肿瘤和来自哪些领域 肿瘤的产生；2.研究全身化疗在慢性粒细胞白血病患者中的作用 转移性膀胱癌；3.研究全身化疗作为一种 膀胱癌患者术前放疗和膀胱切除术的辅助治疗 浸润性膀胱癌；4.放化疗联合化疗的研究 不能手术的浸润性膀胱癌患者的化疗；以及 5.浅表膀胱癌患者的膀胱内治疗 癌症。

The objective of the collaborative clinical research effort is to improve the care of patients with bladder carcinoma through studies of different aspects of clinical management. The studies are carried out according to well-designed protocols. A Central Pathology Laboratory is responsible for the uniform collection, classification and analysis of pathologic and cytologic material. A Statistical Coordinating Center is responsible for data collection, organization and analyses and the Administrative Center is responsible for program coordination and control. At each participating institution, the specific aims are: 1. To assess and characterize all patients with bladder cancer, their neoplasms, and the fields from which the neoplasm arise; 2. To study systemic chemotherapy in patients with metastatic bladder carcinoma; 3. To study systemic chemotherapy as an adjuvant to preoperative radiotherapy and cystectomy in patients with invasive bladder carcinoma; 4. To study combined radiotherapy and chemotherapy in patients with inoperable, invasive bladder carcinoma; and 5. To study intravesical therapy in patients with superficial bladder cancer.